Immunology & Inflammation Therapeutics
DBV Technologies news and milestones
DBV Technologies: 11 headlines on record, 2 headlines in the last 90 days. Its story counts 1 milestone.
Data updated Nov 16, 2026 · Back to the company report
11Headlines
2In 90 days
1Milestones
Headlines
Sep 212026
News · marketscreener.com
Sep 42026
News · markets.businessinsider.com
Châtillon, France, September 3, 2026DBV Technologies to Participate in Upcoming September Investor ConferencesDBV Technologies (Euronext: DBV - IS...
Jul 312026
News · markets.businessinsider.com
Châtillon, France, July 30, 2026DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on N...
Jul 162026
Press release · globenewswire.com
VIASKIN is a registered trademark of DBV Technologies.
Jun 292026
Dec 31, 20252025
News · amf-france.org
L'Autorité des marchés financiers (AMF) veille à la protection de l'épargne, à l'information des investisseurs et au bon fonctionnement des marchés financiers
Dec 17, 20252025
News · YahooFinance
Châtillon, France, December 16, 2025 DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Y…
Oct 31, 20252025
News · YahooFinance
Here is how DBV Technologies S.A. (DBVT) and Aquestive Therapeutics (AQST) have performed compared to their sector so far this year.
Dec 3, 20242024
Feb 9, 20242024
News · benzinga.com
Sources: the outlets named on each headline, each story once
Milestones
Nov 2026
Went public NASDAQ: DBVT
Each milestone is dated by its source: registers, filings, the press
How to cite
DBV Technologies, News. Alion, Nov 16, 2026. https://alion.io/company/dbv-technologies/news
